Webinar: How to Get Great Place to Work-Certified™
MENU
Nkarta Therapeutics

Nkarta Therapeutics

88%

Employees say this is a great place to work


Company Overview

About The Company

Nkarta is a clinical-stage biotechnology company developing allogeneic, off the shelf natural killer (NK) cell therapies for cancer. Founded in 2015 at the birthplace of biotechnology in South San Francisco, CA, Nkarta became a public company (Nasdaq TX) in 2020.

COMPANY SIZE

99 U.S.-based Employees
(Small)

INDUSTRY

Biotechnology & Pharmaceuticals


Employee Demographics

Tenure

Company Culture at Nkarta Therapeutics

The employee experience below at Nkarta Therapeutics, compared to a typical U.S. based company.

Learn More

88% of employees at Nkarta Therapeutics say it is a great place to work compared to 59% of employees at a typical U.S.-based company.

  • Nkarta Therapeutics
  • 88%
  • Typical Company
  • 59%

Source: Great Place to Work® 2019 U.S. National Employee Engagement Study.

97%
I believe management would lay people off only as a last resort.
96%
People here are given a lot of responsibility.
96%
Management is honest and ethical in its business practices.
95%
Our executives fully embody the best characteristics of our company.
94%
Management is competent at running the business.

Why Work at Nkarta Therapeutics?

See what employees say about what makes Nkarta Therapeutics a great workplace. These words are drawn from employee comments on the Trust Index™ survey.


Don't See Your Company Listed?

Nominate your company today to join Certification Nation

NOMINATE YOUR COMPANY